Merck Will Study Cancidas/Antifungal Combinations In Phase IV Trials

Merck will study Cancidas in combination with other antifungals for invasive aspergillosis treatment.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet